I think there is a difference between having the federal government allow research and having access to marijuana. In the past, the only way for a lab to do research was to aquire cannabis from NIDA.
Not having to jump through impossible hoops and roadblocks to gain access to cannabis is the key for CBIS. I mean NIDA would not allow this reseach by blocking access.
Well, CBIS has its own access and by using specific protocols they can establish a scientific processes to standardize their medicine.
If you listened to Donald Abrams, CBIS scientific board member, you might understand he is noted for hisrigorous clinical work.
IMO, CBIS has a dream team and has bypassed the usual roadblocks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.